Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
Sponsor: Pfizer
This observational or N/A phase trial investigates Community-acquired Pneumonia and Streptococcus Pneumoniae Infection and is currently completed. Pfizer leads this study, which shows 15 recorded versions since 2019 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2022 — Jun 2022 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
-
Mar 2021 — May 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Oct 2019 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Oct 2019 [monthly]
Not Yet Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .